Since the elimination of senescent cells by treatment with a combination of the senolytic drugs dasatinib plus quercetin (D + Q) reduces overall hepatic steatosis in ageing, obese and diabetic mice [5], we tested the efficacy of this treatment in preventing insulin-induced hepatocyte senescence. This evidence concerns the gene INS and fatty liver disease.